Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
185 hedge funds and large institutions have $494M invested in Immunogen Inc in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 68 reducing their positions, and 29 closing their positions.
69% more call options, than puts
Call options by funds: $945K | Put options by funds: $559K
2% less funds holding
Funds holding: 189 → 185 (-4)
14% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 29
23% less capital invested
Capital invested by funds: $640M → $494M (-$146M)
29% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 68
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$28.4M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$19.4M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.05M |
| 4 |
Morgan Stanley
New York
|
+$4.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$12.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$6.17M |
| 3 |
HM
HealthCor Management
New York
|
-$5.52M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.34M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$3.88M |
IMGN Hedge Fund Activity: Q3 2020 in Review
185 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2020, worth a combined $494M — down 23% from $640M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of IMGN and 25 opened new positions — a net loss of 4 holders — while 68 trimmed existing stakes and 48 added.
The largest buyer was RA Capital Management, opening a new position worth an estimated $28.4M. The largest seller was Renaissance Technologies, cutting an estimated $12.8M.
- 185 institutional investors held Immunogen Inc (IMGN) as of Q3 2020, down from 189 in Q2 2020.
- Funds reported $494M of Immunogen Inc stock for Q3 2020, down 23% quarter-over-quarter.
- 25 funds opened new Immunogen Inc positions in Q3 2020 and 29 closed out, a net change of -4 holders.
- The largest Immunogen Inc buyer in Q3 2020 was RA Capital Management, an estimated $28.4M added.
- The largest Immunogen Inc seller in Q3 2020 was Renaissance Technologies, an estimated $12.8M sold.
Based on aggregated 13F filings for Q3 2020.